key: cord-0872426-4oychsu6 authors: zhou, y.; Pei, F.; Wang, L.; Zhao, H.; Li, H.; Ji, M.; Yang, W.; Wang, Q.; Zhao, Q.; Wang, Y. title: Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative date: 2020-05-05 journal: nan DOI: 10.1101/2020.04.28.20083956 sha: 1572b5d59d1775a380929d4fe76c408b4dbb3a58 doc_id: 872426 cord_uid: 4oychsu6 An ongoing outbreak of pneumonia associated with SARS-CoV-2 has now been confirmed globally. In absence of effective vaccines, infection prevention and control through diagnostic testing and quarantine is critical. Early detection and differential diagnosis of respiratory infections increases the chances for successful control of COVID-19 disease. The nucleic acid RT-PCR test is regarded as the current standard for molecular diagnosis with high sensitivity. However, the highest specificity confirmation target ORF1ab gene is considered to be less sensitive than other targets in clinical application. In addition, a large amount of recent evidence indicates that the initial missed diagnosis of asymptomatic patients with SARS-CoV-2 and discharged patients with "re-examination positive" may be due to low viral load, and the ability of rapid mutation of coronavirus also increases the rate of false negative results. We aimed to evaluate the sensitivity of different nucleic acid detection kits so as to make recommendations for the selection of validation kit, and amplify the suspicious result to be reportable positive by means of simple continuous amplification, which is of great significance for the prevention and control of the current epidemic and the discharge criteria of low viral load patients. The coronavirus that caused the outbreak was identified in the case of viral 48 pneumonia in Wuhan in 2019 [1] [2] [3] , and was named 2019-nCoV/SARS-CoV-2 by the 49 World Health Organization (WHO) [2, 4, 5] . SARS-CoV-2 belongs to the coronavirus 50 genus β and its genome is single-stranded, non-segmented positive-sense RNA [6] , 51 which is the seventh known coronavirus that can infect humans [1, 7] . Similar to other 52 pathogenic RNA viruses, the genetic material RNA is the first marker to be detected. 53 Nucleic acid detection or sequencing is currently used in conjunction with pulmonary 54 CT for clinical diagnosis of 9] . As the course of the disease progresses, 55 antibodies IgM and IgG will be produce by the human immune system. Although, 56 antibody tests play a major role in monitoring the response to future immunization 57 strategies and demonstrating previous exposure/immunity, the antibody positive rate 58 often lags behind the nucleic acid detection [10] [11] [12] , and cross-reactions existed in 59 SARS-CoV antigen with autoantibodies [13] . 60 Theoretically, fluorescence quantitative RT-PCR detection is widely used as the 61 molecular diagnosis standard for 15] . Lately, the analysis showed 62 that the pattern of viral load change in COVID-19 patients was similar to that in 63 patients with influenza, but different from that in SARS and MERS (whose viral load 64 peaked about 10 days after the onset of symptoms) [16] [17] [18] [19] . At present, a large 65 number of rapid gene detection technologies have been developed in succession, 66 which has great value for the screening of potential infectors and virus detection. 67 However, with too much emphasis on the "fast" characteristic, it is bound to cause a 68 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. [21, 22] , the low load virus will still lead to false negative or 73 spontaneous negative signals of thermostatic technology. In COVID-19 patients, RT-PCR detection could be positive as early as one day 75 before the onset of symptoms, while most COVID-19 patients cannot be detected 76 before premorbid because of the low copy number of the virus [2, [7, 17, 23] . In 77 addition, some discharged patients appearing "re-examination positive" situation is 78 also because of the persistence of a small number of viruses. Unfortunately, the 79 positive rate of RT-PCR detection of SARS-CoV-2 is only 30%-50% at present [24, 25] 80 due to improper sample collection, storage, and error detection [26] . Furthermore, 81 once the target gene mutated or deleted, the test results will be invalid [27, 28] . RT-PCR nucleic acid detection not only has a high false negative rate [29] , but also 83 has a low sensitivity [30] . Currently, the approved nucleic acid detection kits of the 84 SARS-CoV-2 genome are based on the most conserved and specific open reading 85 frame 1ab (ORF1ab), Envelope protein (E) and nucleocapsid protein (N) [6, 31, 32] . Athough ORF1ab is the highest specificity confirmation target gene, but is considered 87 to be less sensitive than other targets in clinical application [33] , so does the pattern of 88 ORF1ab positive reports cause missed tests? Is it feasible to report based on positive 89 N or E genes? Clinically, it is recommended that samples with suspicious results or 90 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10. 1101 single channel positive results should be re-examined with another manufacturer's kit 91 or method. However, what is the basis for choosing the validation kit? This is a 92 problem that needs to be solved. Prevention (China's CDC) (http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202003/t20200309_214241.html). And 108 the two swabs from nasopharyngeal and oropharyngeal were inserted into one sterile 109 tube containing 3 ml of Virus preservation solution. In addition, environmental 110 specimens were collected from surface in direct contact with the patient, such as inner 111 side of the mask, phone, doorknob, bedside, and etc. Each surface was wiped with one 112 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10.1101/2020.04.28.20083956 doi: medRxiv preprint synthetic fiber swab, and then inserted the swab into a sterile tube listed above. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. To verify the sensitivity of the kits, we took nasopharyngeal and oropharyngeal (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10. 1101 presented in in Figure. 1A. Our solution is as follows ( Figure. were suspected to be infected with the SARS-CoV-2 were enrolled for RT-PCR, and 181 two positive cases and two suspicious cases were found (Table 2) . Then, the 182 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020 . . https://doi.org/10.1101 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020 . . https://doi.org/10.1101 regions. Moreover, study found that a deletion of 382 nucleotides in the ORF8 gene (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 5, 2020. A Novel Coronavirus from Patients with Pneumonia in China Clinical Characteristics of 138 Hospitalized Patients With Coronavirus-Infected Pneumonia in Wuhan, China. JAMA Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of 277 Past Human Coronavirus Outbreaks. Pathogens Genomic characterisation and epidemiology of 2019 novel coronavirus: 279 implications for virus origins and receptor binding Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Viral load of SARS-CoV-2 in clinical samples Combination of RT-qPCR testing and clinical features for diagnosis of 284 COVID-19 facilitates management of SARS-CoV-2 outbreak Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test 288 for SARS-CoV-2 Infection Diagnosis Antibody Detection and Dynamic Characteristics in Patients with COVID-19 Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 292 2019 Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune 294 diseases Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection Primer-directed enzymatic amplification of DNA with a thermostable DNA 298 polymerase Clinical progression and viral load in a community outbreak of 300 coronavirus-associated SARS pneumonia: a prospective study Eleven faces of coronavirus disease 2019 COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2. bioRxiv Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 331 (COVID-19) in China: A Report of 1014 Cases Positive RT-PCR Test Results in Patients Recovered From COVID-19 Database Resources of the National Genomics Data Center in 2020 Analytical sensibility and specificity of two RT-qPCR protocols for 336 SARS-CoV-2 detection performed in an automated workflow. medRxiv Molecular and serological investigation of 2019-nCoV infected patients: 339 implication of multiple shedding routes The Laboratory Diagnosis of COVID-19 Infection: Current Issues and 341 Challenges Value of Diagnostic Testing for SARS-CoV-2/COVID-19 Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR Development of Novel Multiplex Real-time RT-PCR Assays for Detection of 348 MERS-CoV Infection Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection 350 of Nucleocapsid Protein. medRxiv Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural 354 Protein 6 (NSP6) could affect viral autophagy Genetic diversity and evolution of SARS-CoV-2 Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike 358 Illnesses Presenting to a Los Angeles Medical Center Precautions are Needed for COVID-19 Patients with Coinfection of Common 360 Respiratory Pathogens. medRxiv Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan SARS-CoV-2 detection in patients with influenza-like illness Nanopore target sequencing for accurate and comprehensive detection of 366 SARS-CoV-2 and other respiratory viruses. medRxiv Comparison of throat swabs and sputum specimens for viral nucleic acid 368 detection in 52 cases of novel coronavirus (SARS-Cov-2) First Case of 2019 Novel Coronavirus in the United States False-positive results in a recombinant severe acute respiratory 373 syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were 374 rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV False-positive results in a recombinant severe acute respiratory 377 syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent 378 assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant 379 SARS-CoV spike polypeptide We thank members of our laboratories for helpful discussions. 263 YW conceived and designed the study. YZ was the major contributor in drafting the (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10. 1101 Assessment. N Engl J Med, 2020. 382(8): p. 692-694. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. . https: //doi.org/10.1101 //doi.org/10. /2020 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10.1101/2020.04.28.20083956 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020 . . https://doi.org/10.1101 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10. 1101 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 5, 2020. . https://doi.org/10. 1101